MP3•Episode home
Manage episode 513759567 series 3486351
Content provided by Water Tower Research. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Water Tower Research or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In this episode of the WTR Small-Cap Spotlight podcast, Steve Fife, President & CEO, and Carl Aure, CFO of LifeVantage (NASDAQ: LFVN), join Tim Gerdeman and Doug Lane of Water Tower Research to discuss the company’s acquisition of LoveBiome, a fast-growing leader in gut health and direct sales.
They explore how the deal strengthens LifeVantage’s foundation in nutrigenomics, expands its presence in the rapidly growing $14B gut health market, and creates synergies across product lines like P84 and MindBody. Fife and Aure also discuss the integration of consultant networks, expected financial impact, and how LifeVantage is positioning for long-term, science-driven growth.
164 episodes